SCHEMBL2298570

SCHEMBL2298570

CCNC(=O)O.c1scc2c1OCCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.38
BAZ2B Q9UIF8 1/20 0.37
GAA P10253 2/20 0.37
TSHR P16473 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 3/20 0.36
POLB P06746 3/20 0.36
ATM Q13315 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MTNR1A P48039 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HPGD P15428 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2297595 0.83 SMN1; SMN2 (0.39) HTTBAZ2BGAATSHRNPC1
Propionic Acid SCHEMBL23529449 0.82 ATM (0.43) HTTBAZ2BGAATSHRNPC1
Bicarbonate SCHEMBL6623191 0.79 BAZ2B (0.39) HTTBAZ2BGAATSHRKDM4E
Alcohol SCHEMBL360831 0.77 HTT (0.39) HTTBAZ2BGAATSHRNPC1
Methyl Alcohol SCHEMBL1142051 0.74 ITGB2 (0.39) HTTBAZ2BGAATSHRNPC1
Acetic Acid Methyl Ester SCHEMBL28914604 0.74 CYP1A2 (0.43) BAZ2BGAANPC1TP53RAB9A
SCHEMBL28552563 0.74 BAZ2B (0.40) HTTBAZ2BGAATSHRNPC1
Benzene SCHEMBL27610541 0.72 ITGB2 (0.48) HTTBAZ2BGAAKDM4ESMN1; SMN2
Butanol SCHEMBL5243681 0.71 TSHR (0.40) HTTBAZ2BGAATSHRALDH1A1
SCHEMBL2298572 0.70 BAZ2B (0.45) HTTBAZ2BTSHRNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994345-B2 Process for the purification of thiophenes H. C. STARCK GMBH (DE) 2011-08-09 US disclosed
US-20090318710-A1 PROCESS FOR THE PURIFICATION OF THIOPHENES H. C. STARCK GMBH (DE) 2009-12-24 US disclosed
EP-1518859-B1 Process for the purification of thiophenes STARCK H C GMBH CO KG (DE) 2007-03-07 EP disclosed
EP-1518859-A1 Process for the purification of thiophenes H.C. Starck GmbH (DE) 2005-03-30 EP disclosed
US-20050065352-A1 Process for the purification of thiophenes H.C. STARCK GMBH (DE) 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318710-A1 PROCESS FOR THE PURIFICATION OF THIOPHENES C1S, THOP1, GTF2E2 HTT 1747/4885BAZ2B 4722/4885GAA 2931/4885
US-20050065352-A1 Process for the purification of thiophenes C1S, THOP1, GTF2E2 HTT 1747/4885BAZ2B 4722/4885GAA 2931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.